Drug record
What four public record sets show for metoprolol. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.016 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $570.9 million | Details |
| FDA recall records | 43 | Details |
Whether the FDA lists this drug as in short supply.
7 products being discontinued. A maker has told the FDA it will stop making these. That is one maker leaving, not a shortage of the drug:
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Metoprolol Tartrate 25 Mg Tab: pharmacies pay about $0.016 each, or $0.481 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| METOPROLOL SUCC ER 100 MG TAB | Generic | $0.084 per each | $2.52 | Oct 21, 2026 |
| METOPROLOL SUCC ER 200 MG TAB | Generic | $0.181 per each | $5.42 | Oct 21, 2026 |
| METOPROLOL SUCC ER 25 MG TAB | Generic | $0.053 per each | $1.59 | Oct 21, 2026 |
| METOPROLOL SUCC ER 50 MG TAB | Generic | $0.049 per each | $1.48 | Oct 21, 2026 |
| METOPROLOL TARTRATE 100 MG TAB | Generic | $0.029 per each | $0.884 | Oct 21, 2026 |
| METOPROLOL TARTRATE 12.5 MG TB | Generic | $2.84 per each | $85.31 | Oct 21, 2026 |
| METOPROLOL TARTRATE 25 MG TAB | Generic | $0.016 per each | $0.481 | Oct 21, 2026 |
| METOPROLOL TARTRATE 37.5 MG TB | Generic | $0.076 per each | $2.27 | Oct 21, 2026 |
| METOPROLOL TARTRATE 50 MG TAB | Generic | $0.020 per each | $0.614 | Oct 21, 2026 |
| METOPROLOL TARTRATE 75 MG TAB | Generic | $0.154 per each | $4.62 | Oct 21, 2026 |
| KAPSPARGO SPRINKLE 100 MG CAP | Brand | $2.29 per each | $68.81 | Oct 21, 2026 |
| KAPSPARGO SPRINKLE 25 MG CAP | Brand | $1.89 per each | $56.65 | Oct 21, 2026 |
| KAPSPARGO SPRINKLE 50 MG CAP | Brand | $1.89 per each | $56.56 | Oct 21, 2026 |
| LOPRESSOR 10 MG/ML ORAL SOLN | Brand | $1.20 per mL | — | Oct 21, 2026 |
| LOPRESSOR 50 MG TABLET | Brand | $2.42 per each | $72.49 | Jan 21, 2026 |
| TOPROL XL 100 MG TABLET | Brand | $2.08 per each | $62.36 | Jul 1, 2026 |
| TOPROL XL 200 MG TABLET | Brand | $3.32 per each | $99.62 | Jul 1, 2026 |
| TOPROL XL 25 MG TABLET | Brand | $1.39 per each | $41.57 | Jul 1, 2026 |
| TOPROL XL 50 MG TABLET | Brand | $1.39 per each | $41.56 | Jul 1, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $570.9 million for the 5 products below. That is down 30% from $821.1 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Metoprolol Succinate Metoprolol Succinate | $456.0 million | 7,767,909 | $14.15 | $58.70 | $668.0 million |
| Metoprolol Tartrate* Metoprolol Tartrate | $107.0 million | 3,853,938 | $6.73 | $27.77 | $140.4 million |
| Toprol XL Metoprolol Succinate | $5.0 million | 9,214 | $131.61 | $540.83 | $10.8 million |
| Kapspargo Sprinkle Metoprolol Succinate | $2.6 million | 14,577 | $59.75 | $181.61 | $1.3 million |
| Lopressor Metoprolol Tartrate | $309,517 | 257 | $343.53 | $1,204.35 | $518,195 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Metoprolol-Hydrochlorothiazide.
Recalls reported to the FDA that name this drug.
The FDA has 43 recall records that name metoprolol in the product description (40 Class II · 3 Class III). 9 are still marked ongoing.
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Reason: Failed Dissolution Specifications
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Reason: Failed Dissolution Specifications
Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Reason: Failed Dissolution Specifications
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Reason: Failed Dissolution Specifications
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.
Reason: Failed Dissolution Specifications
Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10
Reason: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Metoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-354-10
Reason: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,
Reason: Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00
Reason: Presence of Foreign Substance: metal in tablet
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories
Reason: Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-590-01.
Reason: Failed Dissolution Specification
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for metoprolol. This page is public-record information, not medical advice.